MedTrace Logo

Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

NCT05840575 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-05-03

No results posted yet for this study

Summary

The MyBrain study investigates the brain function of children, adolescents and young adults during and after chemo treatment for cancer. The tests include 1) cognitive skills such as memory and attention; 2) the brain's electrical activity; 3) and biological markers related to brain function.

The aim of the study is to better understand the trajectories of cognitive functioning and measures that have been associated with cognitive impairment in patients treated with chemotherapy.

Conditions

  • Chemotherapy-Related Cognitive Impairment
  • Chemotherapeutic Toxicity
  • Chemo-brain
  • Cancer
  • Childhood Cancer
  • Hodgkin Lymphoma
  • Non Hodgkin Lymphoma
  • Testicular Cancer
  • Sarcoma
  • Leukemia

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Eligibility

Min Age
7 Years
Max Age
29 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2027-03-01
Completion
2027-03-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05840575 on ClinicalTrials.gov